Back to company

EJP PHARMACEUTICAL ApS: Financial statements 2025

CVR: 87923614

EJP PHARMACEUTICAL ApS (CVR 87923614) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -28,266 and a net result of DKK 214,282 compared with DKK 414,071 the year before. Equity amounted to DKK 814,282. The solvency ratio was 90.9%.

Gross Profit
-28,266 kr.
Profit/Loss
214,282 kr.
Equity
814,282 kr.
Total Assets
895,673 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--28 t.214 t.814 t.0
2024--33 t.414 t.4.4 mio.1
2023--34 t.454 t.4.1 mio.1
2022--49 t.-478 t.6.7 mio.1
2021--40 t.443 t.7.3 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like EJP PHARMACEUTICAL ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

EJP PHARMACEUTICAL ApS: The 2024 annual report is outJun 24, 2025

EJP PHARMACEUTICAL ApS has published its annual report for 2024. Gross profit came to DKK -32,946, and the net result was DKK 414,071.

About EJP PHARMACEUTICAL ApS

EJP PHARMACEUTICAL ApS is a Danish company of the type Anpartsselskab based in Skodsborg, founded in 1982. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Ejvind Jersie Pedersen. The company is owned by Ejvind Jersie Pedersen. The company has 1 employee. In 2025, the company reported a gross profit of DKK -28,266 and a net result of DKK 214,282 compared with DKK 414,071 the year before. Equity amounted to DKK 814,282.